Page 6 - Immunic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Inc Today - Breaking & Trending Today

Immunic to Host MS R&D Day and Participate in Investor Conferences in April

NEW YORK, April 4, 2024 /PRNewswire/ Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and. ....

United Kingdom , San Francisco , United States , Hella Kohlhof , Andreas Muehler , Edna Kaplan , Paula Schwartz , Jessica Breu , Daniel Vitt , Exchange Commission , Immunic Inc , Sclerosis Ms Research , Hotel Nikko , Development Rd Day , Rx Communications Group , Multiple Sclerosis , Chief Executive Officer , Chief Medical Officer , Chief Scientific Officer , Accelerating Bio Innovation , Private Securities Litigation Reform Act , Middle East , Annual Report , President Investor Relations ,

AbbVie acquisition signals confidence in small-cap biotech sector's growth potential

AbbVie acquisition signals confidence in small-cap biotech sector's growth potential
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Landos Biopharma , Immunic Inc , Abbvie Inc , Tiziana Life Sciences Ltd , New York City Headquartered , Secondary Progressive , Amyotrophic Lateral Sclerosis ,

Sweet Financial Partners LLC Purchases New Shares in Immunic, Inc. (NASDAQ:IMUX)

Sweet Financial Partners LLC purchased a new stake in Immunic, Inc. (NASDAQ:IMUX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 29,829 shares of the company’s stock, valued at approximately $45,000. Sweet Financial Partners LLC owned 0.07% of Immunic at the […] ....

Sweet Financial Partners , Jpmorgan Chase Co , Blackrock Inc , Northern Trust Corp , Exchange Commission , Immunic Inc , Free Report , Financial Partners , Trust Corp , Two Sigma Investments , Sigma Investments , Stock Down , Get Free Report , Visit Holdingschannel , Immunic Daily ,

Immunic (IMUX) Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium

Immunic (IMUX) Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Daniel Vitt , Robertj Fox , Alexandra Herrmann , Research In Multiple Sclerosis , Neurological Institute , Mellen Center , Immunic Inc , Americas Committee For Treatment , Americas Committee , Multiple Sclerosis , Palm Beach , Chief Executive Officer , Vidofludimus Calcium , Serum Neurofilament , Staff Neurologist , Cleveland Clinic , May Vidofludimus Calcium Potentially , Reduce Fatigue , Manager Translational Pharmacology ,

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Edna Kaplan , Paula Schwartz , Jessica Breu , Daniel Vitt , Robertj Fox , Alexandra Herrmann , Mellen Center , Exchange Commission , Neurological Institute , Research In Multiple Sclerosis , Americas Committee For Treatment , Immunic Inc , Americas Committee , Multiple Sclerosis , Palm Beach , Chief Executive Officer , Vidofludimus Calcium , Serum Neurofilament , Staff Neurologist , Cleveland Clinic , May Vidofludimus Calcium Potentially , Reduce Fatigue , Manager Translational Pharmacology , Private Securities Litigation Reform Act , Annual Report ,